MercoPress, en Español
Montevideo, April 26th 2024 - 17:20 UTC
A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said.
Get our news on your inbox! Suscribe